- Home
- MI/ACS
MI/ACS
Revolutionising Thrombosis Treatment in ACS, SSP and AF
- 1.00
Published:
Learning objectives
- Discuss the unmet needs in thrombosis management, MACE burden after ACS, stroke in AF and secondary stroke prevalence and consequences
- Evaluate the current standard of care for the treatment of ACS, SSP and AF and its limitations
- Review guidelines and critique current prescribing practices and the implications of inadequate treatment
- Explain the different strategies for targeting FXI and how FXI inhibition mechanisms differentiate from traditional anticoagulation therapies
- Identify emerging anticoagulant strategies and describe the efficacy and safety data from Phase 2 FXI inhibitor clinical trials as well as ongoing Phase 3 trials and potential place in therapy for ACS, AF and SSP
- Apply evidence-based anticoagulation strategies by optimising treatment decisions and addressing patient-specific risk factors
Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity
- 1.00
Published:
Learning objectives
- Discuss the current practice gaps in hypercholesterolaemia management
- Recall best practice for assessing CV risk, defining LDL-C targets and offering patient education
- Stratify patients by CV risk category
- Select cholesterol-lowering therapies according to risk category and LDL-C target
Incretin Management in Type 2 Diabetes
- 1.00
Published:
Learning objectives
- Recall the components of the ‘ominous octet’ & how they contribute to T2DM development
- Identify underlying facets of clinical inertia in T2DM care
- Describe how early adoption of intensive glycaemic control leads to better outcomes in T2DM
- Recall efficacy & the mode of action of various incretin-based treatments
- Adopt an early, intensive glucose-lowering strategy in appropriate individuals
- Select appropriate incretin treatment & dosing regimens according to patient profiles
- Identify individuals likely to gain cardiovascular benefit from GLP-1RAs
- Select appropriate actions following adverse events from incretin-based treatments
TIO 2020 – Technologies and Controversies
- 1.00
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
TIO 2020 – Trials
- 1.00
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
TIO 2020 – Live TAVI Cases
- 1.00
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
